The effect of lycopene supplementation on chronic obstructive lung disease

Nobel Medicus

Volumn 8, Issue 3, 2012, Pages 98-104

  Kirkil, Gamze ^a   Muz, Mehmet Hamdi ^a   Sancaktar, Enver ^a   Kaman, Dilara ^a   Şahin, Kazim ^a   Küçük, Ömer ^b  

^a FIRAT UNIVERSITY   (Turkey)

^b EMORY UNIVERSITY   (United States)

Author keywords

Antioxidants; Copd; Lycopene; Oxidants

Indexed keywords

BUDESONIDE; CATALASE; FLUTICASONE; FORMOTEROL; INTERLEUKIN 1BETA; INTERLEUKIN 6; LYCOPENE; MALONALDEHYDE; SALMETEROL; SUPEROXIDE DISMUTASE; THEOPHYLLINE; TIOTROPIUM BROMIDE; TUMOR NECROSIS FACTOR ALPHA;

ADULT; AGED; ARTICLE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; FORCED EXPIRATORY VOLUME; FORCED VITAL CAPACITY; HUMAN; LUNG FUNCTION TEST; MALE; OXIDATIVE STRESS; SPIROMETRY; TREATMENT RESPONSE;

EID: 84872971557     PISSN: 13052381     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (48)

1. Global Initiative for Chronic Obstructive Lung Disease (GOLD) Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease GOLD workshop report, updated 2008.
2. Larsson K.Aspects on pathophysiological mechanisms in COPD J Intern Med 2007; 262:311-340.
3. Domej W, Foldes-Papp Z.Flogel E, Haditsch B.Chronic obstructive pulmonary disease and oxidative stress Curr Pharm Biotechnol 2006; 7:117-123.
4. Dekhuijzen PN, Aben KK, Dekker I, et al.Increased exhalation of hydrogen peroxide in patients with stable and unstable chronic obstructive pulmonary disease.Am J Respir Cnt Care Med 1996; 154:813-816.
5. Nowak D, Kasielski M, Antczak A, Pietras T, Bialasiewicz P Increased content of thiobarbituric acid-reactive substance and hydrogen peroxide in the expired breath condensate of patients with stable chronic obstructive pulmonary disease:no significant effect of cigarette smoking Respir Med 1999,93, 389-396
6. Crapo J D Oxidative stress as an initiator of cytokine release and cell damage.Eur Respir J Suppl 2003; 44- 4-6
7. Bowler RP Barnes PJ, Crapo JD The role of oxidative stres in chronic obstructive pulmonary disease COPD 2004; 1:255-277.
8. Gann PH, Ma J, Giovannucci E, Willett W, Sacks FM.Lower prostate cancer risk in men with elevated plasma lycopene levels:results of a prospective analysis Cancer Res 1999; 59:1225-1230.
9. Agarwal S, Rao AV Tomato lycopene and its role in human health and chronic diseases CMAJ 2000; 163:739-744.
10. Sun X Oberley LW, Ying L A simple method for clinical assay of superoxide dismutase Clin Chem 1988; 34- 497-500.
11. Aebi H.Catalase.In:Bergmeyer U, ed Methods of enzymatic analysis New York and London:Academic Pres, 1974,673-677.
12. Satoh K.Serum Lipid Peroxide in cerebrovascular disorders determined by a new colorimetnc method.Clin Chim Acta 1978; 90:37-43.
13. YagiK.Assay of blood plasma or serum.Methods in enzymology 1984; 105:328-331.
14. Stahl W, Sies H.Uptake of lycopene and its geometrical isomers is greater from heat-processed than from unprocessed tomato juice in humans J Nutr 1992.122:2161-2166.
15. Ishida BK.Ma J Chan B.A simple, rapid method for HPLC analysis of lycopene isomers Phytochem Anal 2001; 12:194-198.
16. Ichinose M, Sugjura H, Yamagata S, et al.Xanthine oxidase inhibition reduces reactive nitrogen species production in COPD airways.Eur Respir J 2003; 22.457-461.
17. Ichinose M.Sugura H, Yamagata S, Koarai A.Shirato K.Increase in reactive nitrogen species production in chronic obstructive pulmonary disease airways Am J Respir Crit Care Med 2000; 162:701-706.
18. McCusker K, Hoidal J, Selective increase of antioxidant enzyme activity in the alveolar macrophages from cigarette smokers and smokeexposed hamsters Am Rev Respir Dis 1990; 141:678-682.
19. Tomaki M, Suigura H, Koarai A, et al.Decreased expression of antioxidant enzymes and increased expression of chemokines in COPD lung Pulmonary Pharmacology & Therapeutics 2007; 20:596-605.
20. Matskevich GK Korotkina RK Devlikanova A, Vishnevskü AA, Karelin AA The study of the antioxidant enzymes in erythrocytes in lung diseases Patol Fiziol Eksp Ter 2003; 2:23-25.
21. Toth KM, Berger EM, Beehler CJ, Repine JE.Erythrocytes from cigarette smokers contain more glutathione and catalase and protect endothelial cells from hydrogen peroxide better than do erythrocytes from nonsmokers Am Rev Respir Dis 1986; 134- 281-284.
22. Zhou JF, Yan XF, Guo FZ, et al.Effects of cigarette smoking and smoking cessation on plasma constituents and enzyme activities related to oxidative stress Biomed Environ Sci 2000; 13:44-55.
23. Ning W, Li CJ Kaminski N et al Comprehensive gene expression profiles reveal pathways related to the pathogenesis of chronic obstructive pulmonary disease.Proc Natl Acad Sci USA 2004; 101:14895-14900.
24. Sadowska AM, Luyten C Vints AM.et al.Systemic antioxidant defences during acute exacerbation of chronic obstructive pulmonary disease.Respirology 2006,11:741 -747.
25. Daga MK, Chhabra R.Sharma B, Mishra TK Effects of exogenous vitamin E supplementation on the levels of oxidants and antioxidants in chronic obstructive pulmonary disease J Biosci 2003; 28:7-11.
26. Kondo X Tagami S, Yoshioka A.Nishimura M, Kawakami Y Current smoking of elderly men reduces antioxidants in alveolar macrophages Am J Respir Crit Care Med 1994; 149:178-182.
27. Mak JQ Ho SP, Yu WC, et al.Polymorphisms and functional activity in superoxide dismutase and catalase genes in smokers with COPQ Eur Respir J 2007; 30:684-690.
28. Kluchova Z, Petrasova D, Joppa PDorkova Z, Tkacova R.The association between oxidative stress and obstructive lung impairment in patients with COPD Physiol Res 2007; 56- 51-56.
29. Saetta M, Turato G Maestrelli PMapp CE, Fabbri LM.Cellular and structural bases of chronic obstructive pulmonary disease Am J Respir Crit Care Med 2001; 163:1304-1309.
30. Rahman I.The role of oxidative stress in the pathogenesis of COPD-implications for therapy.Treat Respir Med 2005; 4, 175-200.
31. MacNee W, Rahman I.Oxidants and antioxidants as therapeutic targets in chronic obstructive pulmonary disease.Am J Respir Crit Care Med 1999,160:558-565.
32. Colak Q Alatas O. Akyüz E., et al. Antioxidant status in chronic obstructive pulmonary disease Tr J Med S Sci 1995; 24- 305-307.
33. Calikogiu M, Onlu A, Tamer L, et al.The levels of serum vitamin Q malondialdehyde and erytrocyte reduced glutathione in chronic pulmonary disease and in healthy smokers.Clin Chem Lab Med 2002; 40:1028-1031.
34. Karadag F, Cildag O, Altinisik M, et al.Trace elements as a component of oxidative stres in COPD Respirology 2004; 9- 33-37.
35. Walda IC Tabak C, Smit HA, et al.Diet and 20-year chronic obstructive pulmonary disease mortality in middle-aged men from three European countries Eur J Clin Nutr 2002; 56:638-643
36. Hu G, Cassano PA.Antioxidant nutrients and pulmonary function:the Third National Health and Nutrition Examination Survey [NHANES III].Am J Epidemiol 2000; 151:975-981.
37. Brown KM, Morrice PC Duthie GG Vitamin E supplementation suppresses index of lipid peroxidation and platelet count, in blood of smokers and nonsmokers but plasma lipoprotein concentrations remain unchanged Am J Nutr 1994,60:383-387.
38. Wu TC Huang YC, Hsu SY.Wang YC Yeh SL Vitamin E and vitamin C supplementation in patients with chronic obstructive pulmonary disease Int J Vltam Nutr Res 2007; 77:272-279.
39. Nadeem A, Raj HG Chhabra SK.Effect of vitamin E supplementation with standard treatment on oxidantantioxidant status in chronic obstructive pulmonary disease Indian J Med Res 2008; 128:705-711.
40. Habib MP, Tank U, Lane LC, Garewal HS Effect of vitamin Eon exhaled ethane in cigarette smokers Chest 1999,115:684-690.
41. Arab L, Steck-scott S, Fleishauer AT Lycopene and the Lung Exp Biol Med 2002; 227:894-899.
42. Harris RW, Key TJ Silcocks PB et al.A case-control study of dietary carotene in men with lung cancer and in men with other epithelial cancers.Nutr Cancer 1991; 15:63-68.
43. Knekt P Jarvinen R, Teppo L, et al.Role of various carotenoids in lung cancer prevention.J Natl Cancer Inst 1999,91:182-184.
44. Satia JA, Littman A, Slatore CG, Galanko JA, White E.Long-term use of beta-caratene, retinol, lycopene and lutein supplements and lung cancer risk:results from the VITamins and Lifestyle (VITAL) study Am J Epidemiol 2009,169:815-828.
45. Devaraj S, Mathur S, Basu A, et al.A dose-response study on the effects of purified lycopene supplementation on biomarkers of oxidative stres J Am Coll Nutr 2008; 27- 267-273.
46. Li BH, Zhang QX, Dong DJ Lin XM. Effect of lycopene on immunity in rats with acute lung injury Beijing Da Xue Xue Bao 2007,39.77-82.
47. Lee CM, Chang JH, Moon DO, et al.Lycopene suppresses ovalbumin-induced airway inflammation in a murine model of asthma.Biochem Biophys Res Commun 2008; 374:248-252.
48. Kasagj S, Seyama K, Mori H, et al.Tomato juice prevents senescence-accelerated Mouse P1 strain from developing emphysema induced by chronic exposure to tobacco smoke.Am J Physiol Lung Cell Mol Physiol 2006; 290- 396-404